Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis

Journal of the Neurological Sciences

Volumn 150, Issue 1, 1997, Pages 59-62

  Bromberg, Mb ^a   Wald, Jj ^b   Forshew, Da ^a   Feldman, El ^b   Albers, Jw ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Azathioprine; Corticosteroids; Immunosuppression; Myasthenia gravis; Prednisone; Treatment

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HUMAN; IDIOSYNCRASY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYALGIA; MYASTHENIA GRAVIS; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; AZATHIOPRINE; CROSS-OVER STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; PREDNISONE;

EID: 0030845460     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05370-7     Document Type: Article

References (14)

1. Brunner, N.G., Berger, C.L., Namba, T. and Grob, D. (1996) Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Ann. NY. Acad. Sci., 274: 577-595.
2. Chaudhry, V., Cornblath, D.R. Immunosuppressive therapy for myasthenia gravis. In: Lisak, R.P., (Ed.) Handbook of myasthenia gravis and myasthenic syndromes. Marcel Dekker, New York, 1994, pp. 341-374.
3. Gajdos, P., Ekharrat, D., Chevret, S., Dhastang, C., Raphael, J.-C., Bolgert, F., Eymard, B., Woimant, F., Morcamp, D., Tournihac, M. and Dupuis, M. (1993) A randomized clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J. Neurol. Neurosurg. Psychiatry, 56: 1157-1163.
4. Hohlfeld, R., Michels, M., Heininger, K., Besinger, U. and Toyka, K.V. (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenai gravis. Neurology, 38: 258-261.
5. Kissel, J.T., Levy, R.J., Mendell, J.R., and Griggs, R.C. (1986) Azathioprine toxicity in neuromuscular disease. Neurology, 36: 35-39.
6. Krueger, J.G., Tallent, M.B., Richie, R.E., Johnson, H.K., MacDonnel, R.C. and Turner, B. (1985) Neoplasia in immunosuppressed renal transplant patients: a 20-year experience. Southern Med. J., 78: 501-505.
7. van Swieten, J.C., Koudstaal, P.J., Visser, M.C., Schouten, H.J.A. and van Gijn, J. (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19: 604-607.
8. Tindall, R.S.A., Rollins, J.A., Phillips, J.T., Greenlee, R.G., Wells, L. and Belendiuk, G. (1987) Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. New Engl. J. Med., 316: 719-724.
9. Matell, G., Immunosuppressive drugs: Azathioprine in the treatment of myasthenia gravis. In: Drachman D.B., (Ed.) Myasthenia gravis: biology and treatment. Ann. New York Acad. Sci., 1987; 505: 588-594.
10. Miano, M.A., Bosley, T.M., Heiman-Patterson, T.D., Reed, J., Sergott, R.C., Savino, P.J. and Schatz, N.J. (1991) Factors influencing outcome of prednisone dose reduction in myasthenia gravis. Neurology, 41: 919-921.
11. Palace, J., Newsom-Davis, J. and Lecky, B. (1996) The Myasthenia Study Group: A multicenter, randomized double-blind trial of prednisolone plus azathioprine versus prednisolone plus placebo in myasthenia gravis. Neurology, 46 (Suppl) A332.
12. Pascuzzi, R.M., Coslett, B.H. and Johns, T.R. (1984) Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann. Neurol., 15: 291-298.
13. Witte, A.S., Cornblath, D.R., Parry, G.J., Lisak, R.P. and Schatz, N.J. (1984) Azathioprine in the treatment of myasthenia gravis. Ann. Neurol., 15: 602-605.
14. Sghirlanzoni, A., Peluchetti, D., Mantegazza, R., Fiacchino, F. and Cornelio, F. (1984) Myasthenia gravis: prolonged treatment with steroids. Neurology, 34: 170-174.